Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Bruchim

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 27, 2019
An Israeli Gynecologic Oncology Group study of statin use and endometrial cancer prognosisYakir Segev, Ofer Gemer, Limor Helpman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 6, 2019
The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Limor Helpman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2020
Increased ultrasonographic endometrial thickness is associated with poor survival in patients with endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Nasreen Hag-Yahia, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 22, 2020
Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort studyNasreen Hag-Yahia, Ofer Gemer, Ram Eitan, et al.
American Journal of Clinical Oncology|March 4, 2015
Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical CancerOfer Gemer, Ofer Lavie, Michael Gdalevich, et al.
American Journal of Obstetrics and Gynecology|May 25, 2018
Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group studyOfer Gemer, Yakir Segev, Limor Helpman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2014
Integration of PET/CT into the preoperative evaluation of patients with early cervical cancer does not decrease the proportion of patients with positive lymph nodes found after surgeryOfer Gemer, Ram Eitan, Michael Gdalevich, et al.
Therapeutic Advances in Medical Oncology|December 30, 2025
SALVOVAR: a pragmatic randomized phase III trial comparing the SALVage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic OVARian cancersClaire Chator, Nozomu Yanaihara, Sylvie Chabaud, et al.
Gynecologic Oncology|May 30, 2018
Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group StudyYael Yagur, Omer Weitzner, Ofer Gemer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2015
The European Network for Gynaecological Oncological Trial Groups Charta for Privileged PartnershipChristian Marth, Andreas du Bois, Christian Schauer, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 27, 2019
An Israeli Gynecologic Oncology Group study of statin use and endometrial cancer prognosisYakir Segev, Ofer Gemer, Limor Helpman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 6, 2019
The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Limor Helpman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2020
Increased ultrasonographic endometrial thickness is associated with poor survival in patients with endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Nasreen Hag-Yahia, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 22, 2020
Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort studyNasreen Hag-Yahia, Ofer Gemer, Ram Eitan, et al.
American Journal of Clinical Oncology|March 4, 2015
Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical CancerOfer Gemer, Ofer Lavie, Michael Gdalevich, et al.
American Journal of Obstetrics and Gynecology|May 25, 2018
Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group studyOfer Gemer, Yakir Segev, Limor Helpman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2014
Integration of PET/CT into the preoperative evaluation of patients with early cervical cancer does not decrease the proportion of patients with positive lymph nodes found after surgeryOfer Gemer, Ram Eitan, Michael Gdalevich, et al.
Therapeutic Advances in Medical Oncology|December 30, 2025
SALVOVAR: a pragmatic randomized phase III trial comparing the SALVage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic OVARian cancersClaire Chator, Nozomu Yanaihara, Sylvie Chabaud, et al.
Gynecologic Oncology|May 30, 2018
Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group StudyYael Yagur, Omer Weitzner, Ofer Gemer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2015
The European Network for Gynaecological Oncological Trial Groups Charta for Privileged PartnershipChristian Marth, Andreas du Bois, Christian Schauer, et al.
Pageof 9